ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pain

The Gender Effect

Kurt Ullman  |  March 1, 2009

Are gender-based differences in rheumatic and autoimmune disease clinically relevant or statistical artifact?

Filed under:Conditions Tagged with:AutoimmuneGendergenetics

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2009

Information on safety, labeling changes, and pharmaceutical research

Filed under:Drug Updates Tagged with:ApprovalsPipeline

Help Patients with Scleroderma Manage Musculoskeletal and Functional Limitations

Staff  |  February 1, 2009

On March 10, Janet Poole, PhD, OTR, professor of the occupational therapy graduate program at the University of New Mexico in Albuquerque, will continue the ARHP’s Audioconference/Webcast Series with the management of scleroderma. Dr. Poole received her BS in occupational therapy from Colorado State University, her MA degree in educational psychology from the University of North Carolina, Chapel Hill, and her PhD in motor learning/motor control from the University of Pittsburgh. Dr. Poole’s research interest is in scleroderma and the functional impact of the disease on the tasks of daily living, oral hygiene, parenting, and employment. She has conducted a number of studies examining rehabilitation interventions with people who have scleroderma and, with a colleague, is developing a self-management program for these patients. She has also authored several textbook chapters on rehabilitation for people with scleroderma.

Filed under:From the College Tagged with:Association of Rheumatology Professionals (ARP)ManagementSclerodermaTreatment

Fibromyalgia

Staff  |  February 1, 2009

Patient Fact Sheet

Filed under:ConditionsFrom the CollegePain Syndromes Tagged with:FibromyalgiaPatient Fact Sheet

Coding Corner Question

Staff  |  February 1, 2009

February’s Coding Challenge

Filed under:Billing/CodingConditionsOsteoarthritis and Bone DisordersPractice Support Tagged with:BillingCodingOsteoporosisPain

Take Our Regulators—Please!

David S. Pisetsky, MD, PhD  |  February 1, 2009

May 2009 bring us a return to constructive, thoughtful oversight in all fields

Filed under:Legislation & AdvocacyOpinionRheuminationsSpeak Out Rheum Tagged with:Healthcare ReformPoliticsRegulation

Biologic Logic: Making Sense of Current Therapies for Rheumatic Diseases

Staff  |  January 1, 2009

Continuing the ARHP 2009 Audioconference/Webcast series, Daniel F. Battafarano, DO, FACP, FACR, will discuss the use of biologic therapy in the treatment of rheumatology patients on February 10 from noon to 1:00 pm ET. During the session, Dr. Battafarano will review basic immunology, inflammation, and relevant cytokines for common rheumatic diseases. In addition, he will describe the current biologic therapies and their relationship to rheumatic disease outcomes, and identify future biologic strategies for therapy.

Filed under:From the College Tagged with:Association of Rheumatology Professionals (ARP)Biologicsrheumatic diseasesTherapies

Juvenile Idiopathic Arthritis

Staff  |  January 1, 2009

Patient Fact Sheet

Filed under:ConditionsFrom the CollegeOther Rheumatic Conditions Tagged with:Juvenile idiopathic arthritisPatient Fact Sheet

New Research Yields Significant Advances in RA Detection and Treatment

Staff  |  January 1, 2009

F or the first time during its unprecedented initiative to find a cure for rheumatoid arthritis (RA), the ACR Research and Education Foundation (REF) is releasing new information acquired from research funded by the Within Our Reach campaign.

Filed under:From the CollegeResearch Rheum Tagged with:REF NewsResearchTreatment

Documentation History in Evaluation and Management Services

Staff  |  January 1, 2009

Does your staff know what is involved in taking a complete history from a patient?

Filed under:From the College Tagged with:EvaluationPractice Updates

  • « Previous Page
  • 1
  • …
  • 233
  • 234
  • 235
  • 236
  • 237
  • …
  • 249
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences